Mitchell Parrish, JD, RAC, CIP, VP of Legal and Regulatory Affairs
Regenerative medicine is complex, and so are the regulations and laws that govern such medicine. The 21st Century Cures Act continues this trend of complexity, but does offer some solace: implicit congressional support for regenerative therapies. This support includes $30 million in funding and new FDA approval pathways. For those in the regenerative medicine space, including transplant and stem cell researchers, this should prove welcome news.